A clinical trial for evaluation of leech application in the management of Vicarcikā (Eczema)

BACKGROUND: Skin diseases are among the most common health problems worldwide and are associated with a considerable burden. Eczema is such a skin ailment which cause psychological, social and financial burden on the patient and their families. Management of eczema with antibiotics, antihistamines, steroids etc., are available but even after their use relapses, recurrences and other complications are very common. AIM: The aim of this study was to assess the efficacy of leech application in the management of vicarcikā (Eczema) with standard clinical parameters viz. Eczema Area and Severity Index (EASI) score, SCORing of Atopic Dermatitis (SCORAD) Index and Dermatology Life Quality Index (DLQI). MATERIALS AND METHODS: An open labeled clinical trial study without control group was conducted with 27 patients having the classical symptoms of vicarcikā (Eczema), selected as per the inclusion and exclusion criteria from outpatient department and inpatient department sections of Shalya Department, S.V. Ayurvedic Hospital, Tirupati. Minimum four sittings of leech application were carried out with 7 days interval. Pre- and post-treatment evaluation of the patient was done with Eczema Area and Severity Index (EASI) score, SCORing of Atopic Dermatitis (SCORAD) Index and Dermatology Life Quality Index (DLQI). STATISTICAL ANALYSIS: Analysis of the data was done with Student's paired t-test. RESULTS: The total EASI score showed considerable reduction up to 54.45% (P < 0.01) and the SCORAD Index significantly reduced by 55% (P < 0.01). The life quality of the patient calculated by DLQI improved significantly by 62.36% (P < 0.01). CONCLUSION: Leech application gives significant relief for the symptoms of eczema. The life quality of the patient also improved significantly after leech therapy. No adverse reactions were reported during the entire course of study.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

In an open-label trial, 27 patients with vicarcikā (eczema) received at least four leech applications; EASI scores fell up to 54.45%, SCORAD by 55% and quality-of-life (DLQI) improved 62.36%, all P < 0.01, with no adverse reactions.

Explore how this research connects to clinical practice

More peer-reviewed studies in Safety & Infection Control.

• Improvement of patient care through hirudotherapy and the management of leeches from their reception to their disposal in France — Vaesken C et al. (2023)
• Hirudotherapy (medicinal leeches) for treatment of upper airway obstruction in a dog — Trenholme H, Masseau I, Reinero C (2021)
• Analysis of antibiotic resistant infections associated with hirudotherapy — Brauer P et al. (2024)
• Kounis syndrome due to hirudotherapy (leech therapy) in emergency department; a case report — Çakmak T et al. (2018)
• Complications of leech therapy — Pourrahimi M, Abdi M, Ghods R (2020)
• Medicinal leech therapy and Aeromonas spp. infection — Verriere B et al. (2016)
• Rethinking antimicrobial prophylaxis in patients receiving medicinal leech therapy — McCracken J, Koehler S, Sharma R (2022)
• Prophylactic use of levofloxacin during medicinal leech therapy — Bauters T et al. (2014)
• Leech Application-related Upper Gastrointestinal Bleeding: A Case Report — Dolek U et al. (2023)
• Icaridin-Loading Nitrocellulose As a New Repellent Against Aquatic Leech with Waterproof and Long-Acting Properties — Zeng W et al. (2022)

Browse all ASH-analysed research →